Yulei Cheng

No ORCID on file · 2 papers in corpus · active 2017-2025

Study types

  • article 1
  • other 1

Condition tags

  • endometriosis 2
  • infertility 1
other 2025
Endostatin-expressing endometrial mesenchymal stem cells inhibit angiogenesis in endometriosis through the miRNA-21-5p/TIMP3/PI3K/Akt/mTOR pathway
Stem cells translational medicine ·doi:10.1093/stcltm/szae079

Endometriosis is a chronic inflammatory and neoangiogenic disease. Endostatin is one of the most effective inhibitors of angiogenesis. Mesenchymal stem cells (MSCs) have been investigated as compelling options for cell therapy. However, the…

article 2017
Characteristics of Human Endometrium-Derived Mesenchymal Stem Cells and Their Tropism to Endometriosis
Stem cells international ·doi:10.1155/2017/4794827

Human endometrial tissue has become an attractive source of mesenchymal stem cells (MSCs) for cell-based therapies because these MSCs can be easily harvested and have tumour tropism as well as reduced immunogenic and inflammatory properties…